Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Daniel P Wickland"'
Autor:
Yi Lin, Yan W Asmann, Barath Shreeder, Keith L Knutson, Erik Jessen, Daniel P Wickland, Colton McNinch, Brian Necela
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 12, Iss 5 (2024)
Background Cancer neoantigens arise from protein-altering somatic mutations in tumor and rank among the most promising next-generation immuno-oncology agents when used in combination with immune checkpoint inhibitors. We previously developed a comput
Externí odkaz:
https://doaj.org/article/bf5610643ea74733ae707eb219999a5b
Autor:
Daniel P Wickland, Yingxue Ren, Jason P Sinnwell, Joseph S Reddy, Cyril Pottier, Vivekananda Sarangi, Minerva M Carrasquillo, Owen A Ross, Steven G Younkin, Nilüfer Ertekin-Taner, Rosa Rademakers, Matthew E Hudson, Liudmila Sergeevna Mainzer, Joanna M Biernacka, Yan W Asmann
Publikováno v:
PLoS ONE, Vol 16, Iss 4, p e0249305 (2021)
Genetic studies have shifted to sequencing-based rare variants discovery after decades of success in identifying common disease variants by Genome-Wide Association Studies using Single Nucleotide Polymorphism chips. Sequencing-based studies require l
Externí odkaz:
https://doaj.org/article/2e9708b8dcae4ea494fdb98162313af4
Autor:
Yingxue Ren, Yesesri Cherukuri, Daniel P. Wickland, Vivekananda Sarangi, Shulan Tian, Jodi M. Carter, Aaron S. Mansfield, Matthew S. Block, Mark E. Sherman, Keith L. Knutson, Yi Lin, Yan W. Asmann
Publikováno v:
OncoImmunology, Vol 9, Iss 1 (2020)
Tumors acquire numerous mutations during development and progression. When translated into proteins, these mutations give rise to neoantigens that can be recognized by T cells and generate antibodies, representing an exciting direction of cancer immu
Externí odkaz:
https://doaj.org/article/f28c86fc6b8d4534a55511cd2277d5f5
Publikováno v:
JNCI: Journal of the National Cancer Institute. 114:1192-1199
BackgroundIn the United States, cancer disproportionately impacts Black and African American individuals. Identifying genetic factors underlying cancer disparities has been an important research focus and requires data that are equitable in both quan
Autor:
Christina M. Moloney, Chia‐Chen Liu, Daniel P. Wickland, Elizabeth R. Lesser, Jennifer Kachergus, Marka M. Van Blitterswijk, Neill R. Graff‐Radford, Dennis W. Dickson, E. Aubrey Thompson, Melissa E. Murray
Publikováno v:
Alzheimer's & Dementia. 18
Autor:
Yan W. Asmann, Kathleen M. Egan, Mark E. Sherman, Steven Goodison, Keith L. Knutson, Derek C. Radisky, Kathryn J. Ruddy, Daniel P. Wickland, Joshua W. Ogony
Publikováno v:
Cancer Prev Res (Phila)
The etiology of triple-negative breast cancers (TNBC) is poorly understood. As many TNBCs develop prior to the initiation of breast cancer screening or at younger ages when the sensitivity of mammography is comparatively low, understanding the etiolo
Publikováno v:
JNCI: Journal of the National Cancer Institute. 114:1729-1730
Autor:
Yan W. Asmann, Yi Lin, Mark E. Sherman, Aaron S. Mansfield, Keith L. Knutson, Yesesri Cherukuri, Yingxue Ren, Shulan Tian, Daniel P. Wickland, Jodi M. Carter, Vivekananda Sarangi, Matthew S. Block
Publikováno v:
Oncoimmunology
OncoImmunology, Vol 9, Iss 1 (2020)
OncoImmunology, Vol 9, Iss 1 (2020)
Tumors acquire numerous mutations during development and progression. When translated into proteins, these mutations give rise to neoantigens that can be recognized by T cells and generate antibodies, representing an exciting direction of cancer immu
Autor:
Wei Wei, Shilpa Manjunatha, Fernando Cezar Juliatti, Steven J. Clough, Adriana de andrade Figueiró, Daniel P. Wickland, Xing Wu, Ana Carolina Oliveira Mesquita, Matthew E. Hudson
Publikováno v:
BMC Genomics, Vol 18, Iss 1, Pp 1-16 (2017)
BMC Genomics
BMC Genomics
Background Sclerotinia Stem Rot (SSR), caused by the fungal pathogen Sclerotinia sclerotiorum, is ubiquitous in cooler climates where soybean crops are grown. Breeding for resistance to SSR remains challenging in crops like soybean, where no single g
Autor:
Vivekananda Sarangi, Matthew E. Hudson, Jason P. Sinnwell, Rosa Rademakers, Cyril Pottier, Owen A. Ross, Joseph S. Reddy, Yan W. Asmann, Nilufer Ertekin-Taner, Liudmila Sergeevna Mainzer, Minerva M. Carrasquillo, Steven G. Younkin, Joanna M. Biernacka, Daniel P. Wickland, Yingxue Ren
Publikováno v:
PLoS ONE
PLoS ONE, Vol 16, Iss 4, p e0249305 (2021)
PLoS ONE, Vol 16, Iss 4, p e0249305 (2021)
Background: Genetic studies have shifted to sequencing-based rare variants discovery after decades of success in identifying common disease variants by Genome-Wide Association Studies using Single Nucleotide Polymorphism chips. Sequencing-based studi